Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8679290 | Thrombosis Research | 2018 | 5 Pages |
Abstract
- The VTE prevalence in head and neck cancer patients undergoing surgery is 5%.
- Few studies systematically screened included patients for VTE.
- Administration of thromboprophylaxis is inconsistent in head and neck cancer surgery.
- Current thromboprophylatic guidelines are not followed.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Mikkel Lundbech, Andreas Engel Krag, Anne-Mette Hvas,